DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA

DETECTION OF MODIFIED LIPOPROTEINS IN ATHEROSCLEROTIC LESIONS OF HUMAN AORTA

Abstract. Specific autoantibodies against acetylated, maleylated and malonic dialdehyde-(MDA)-modified lipoproteins are detectable in human plasma. Immunization of rabbits with autologous, correspondingly modified low-density lipoproteins (LDLs) did induce autoantibodies against acetylated, maleylat...

Full description

Bibliographic Details
Main Authors:	P. V. Pigarevsky, O. Yu. Archipova, A. D. Denisenko
Format:	Article
Language:	Russian
Published:	St. Petersburg branch of the Russian Association of Allergologists and Clinical Immunologists 2014-07-01
Series:	Медицинская иммунология
Subjects:	autoantibodies modified lipoproteins vascular wall immunohistochemistry
Online Access:	https://www.mimmun.ru/mimmun/article/view/537

Similar Items

ANTIBODIES TO LOW DENSITY LIPOPROTEINS MODIFIED BY MALONIDALDEHYDE: CONTENT IN BLOOD AND ROLE IN ATHEROGENESIS
by: Anna Andreevna Ivanova, et al.
Published: (2019-08-01)

Lipoprotein(a), Immunity, and Inflammation in Polyvascular Atherosclerotic Disease
by: Narek A. Tmoyan, et al.
Published: (2021-01-01)

The Initial Human Atherosclerotic Lesion and Lipoprotein Modification—A Deep Connection
by: Michael Torzewski
Published: (2021-10-01)

Definition of the immunogenic forms of modified human LDL recognized by human autoantibodies and by rabbit hyperimmune antibodies
by: Gabriel Virella, et al.
Published: (2004-10-01)

Serum Lipoprotein(a) Levels in Patients with Atherosclerotic Peripheral Vascular Disease in Hospital Kuala Lumpur
by: N.A. Hakim, et al.
Published: (2008-01-01)

Lipoprotein Glomerulopathy-Like Lesions in Atherosclerotic Mice Defected With HDL Receptor SR-B1
by: Jiawei Liao, et al.
Published: (2021-10-01)

Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis
by: Martina B. Lorey, et al.
Published: (2022-03-01)

Anti-High-Density Lipoprotein Antibodies and Antioxidant Dysfunction in Immune-Driven Diseases
by: Javier Rodríguez-Carrio, et al.
Published: (2018-04-01)

Human plasma lipoproteins /
by: Fruchart, J. C., et al.
Published: (1989)

Facile Preparation of β-Cyclodextrin-Modified Polysulfone Membrane for Low-Density Lipoprotein Adsorption via Dopamine Self-Assembly and Schiff Base Reaction
by: Fei Fang, et al.
Published: (2024-02-01)

Lipoprotein(a) and Its Autoantibodies in Association with Calcific Aortic Valve Stenosis
by: Anna L. Burdeynaya, et al.
Published: (2023-03-01)

Serum lipid, lipoprotein and oxidatively modified low density lipoprotein levels in active or inactive patients with behçet′s disease
by: Fuat Cimen, et al.
Published: (2012-01-01)

Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells
by: Catherine M. Desrumaux, et al.
Published: (2003-08-01)

Metabolic fate of rat and human lipoprotein apoproteins in the rat
by: Shlomo Eisenberg, et al.
Published: (1973-07-01)

Scavenger receptor BI promotes cytoplasmic accumulation of lipoproteins in clear-cell renal cell carcinoma
by: Srividya Velagapudi, et al.
Published: (2018-11-01)

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk
by: Hidekatsu Yanai, et al.
Published: (2022-11-01)

Protein S on the surface of plasma lipoproteins: a potential mechanism for protein S delivery to the atherosclerotic plaques?
by: Marcello Baroni, et al.
Published: (2022-10-01)

Increased low density lipoprotein degradation in aorta of irradiated mice is inhibited by preenrichment of low density lipoprotein with α-tocopherol
by: D.L. Tribble, et al.
Published: (2000-10-01)

High-Density Lipoprotein (HDL) Triglyceride and Oxidized HDL: New Lipid Biomarkers of Lipoprotein-Related Atherosclerotic Cardiovascular Disease
by: Fumiaki Ito, et al.
Published: (2020-04-01)

Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis
by: O I Afanasievа, et al.
Published: (2016-09-01)

The formation and consequences of cholesterol-rich deposits in atherosclerotic lesions
by: Frederick R. Maxfield, et al.
Published: (2023-02-01)

Cardiovascular complications and increased levels of circulating modified low density lipoprotein in HIV patients and patients with lipodystrophy
by: K.R.O.M. Ronchini, et al.
Published: (2004-01-01)

Recent advances in lipoprotein and atherosclerosis: A nutrigenomic approach
by: Sergio López, et al.
Published: (2009-03-01)

Plasma lipoprotein (a) and tissue plasminogen activator are associated with increased risk of atherosclerotic cardiovascular disease
by: Fadia Mayyas, et al.
Published: (2022-07-01)

Secretion of apoB- and apoA-I-containing lipoproteins by chick kidney
by: Patrizia Tarugi, et al.
Published: (1998-04-01)

A Leap above Friedewald Formula for Calculation of Low-Density Lipoprotein-Cholesterol
by: Reema Kapoor, et al.
Published: (2015-01-01)

Lipolysis of emulsion models of triglyceride-rich lipoproteins is altered in male patients with abdominal aorta aneurysm
by: J.J. Hosni, et al.
Published: (2007-03-01)

Differential binding of triglyceride-rich lipoproteins to lipoprotein lipase
by: Shi-Qin Xiang, et al.
Published: (1999-09-01)

Lipid and lipoprotein profiles among middle aged male smokers: a study from southern India
by: Ramachandran Meenakshisundaram, et al.
Published: (2010-10-01)

Shared Risk Factors between Dementia and Atherosclerotic Cardiovascular Disease
by: Liv Tybjærg Nordestgaard, et al.
Published: (2022-08-01)

Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment
by: Stamatios Lampsas, et al.
Published: (2023-01-01)

Lipoprotein(a) and Atherosclerotic Cardiovascular Disease: Where Do We Stand?
by: Georgios Tsioulos, et al.
Published: (2024-03-01)

The heterogeneity of lipoproteins and their role in the development of cardiovascular diseases
by: E. A. Utkina, et al.
Published: (2019-06-01)

Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood
by: Saeed Shoar, et al.
Published: (2021-06-01)

HIGH-DENSITY LIPOPROTEINS AND CARDIOVASCULAR DISEASE
by: Stephen J. Nicholls, et al.
Published: (2020-10-01)

Residual Risk of Atherosclerotic Cardiovascular Events in Relation to Reductions in Very‐Low‐Density Lipoproteins
by: Patrick R. Lawler, et al.
Published: (2017-12-01)

Dependence of local carotid arterial stiffness on the presence of atherosclerotic plaque in the carotid basin in hypertensive patients
by: A. O. Bohun
Published: (2024-02-01)

Lipoprotein(a) and residual vascular risk in statin-treated patients with first acute ischemic stroke: A prospective cohort study
by: Lanjing Wang, et al.
Published: (2022-11-01)

Chemically Modified Biomimetic Carbon-Coated Iron Nanoparticles for Stent Coatings: In Vitro Cytocompatibility and In Vivo Structural Changes in Human Atherosclerotic Plaques
by: Shamil Akhmedov, et al.
Published: (2021-07-01)

Peroxisome Proliferator-Activated Receptor α in Lipoprotein Metabolism and Atherosclerotic Cardiovascular Disease
by: Elena Valeria Fuior, et al.
Published: (2023-10-01)